• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Hydroxybenzoic acid derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Hydroxybenzoic acid derivatives

Recent Advances in the Study of 2-Ethyl-6-hydroxybenzoic acid (CAS: 59681-42-4): A Comprehensive Research Brief

2-Ethyl-6-hydroxybenzoic acid (CAS: 59681-42-4) is a phenolic acid derivative that has garnered significant attention in the chemical, biological, and pharmaceutical research communities due to its versatile applications and potential therapeutic benefits. Recent studies have explored its chemical properties, biological activities, and potential uses in drug development, making it a compound of considerable interest. This research brief aims to provide an up-to-date overview of the latest findings related to this compound, highlighting its significance in contemporary research.

The chemical structure of 2-Ethyl-6-hydroxybenzoic acid features a hydroxybenzoic acid backbone with an ethyl substituent at the 2-position, which contributes to its unique physicochemical properties. Recent research has focused on elucidating its synthesis pathways, stability under various conditions, and interactions with biological molecules. Advanced spectroscopic techniques, including NMR and mass spectrometry, have been employed to characterize its structure and confirm its purity, ensuring reliable data for further studies.

In the realm of biological activity, 2-Ethyl-6-hydroxybenzoic acid has demonstrated promising antimicrobial and anti-inflammatory properties. A 2023 study published in the Journal of Medicinal Chemistry revealed that this compound exhibits inhibitory effects against a range of Gram-positive and Gram-negative bacteria, suggesting its potential as a lead compound for developing new antibiotics. Additionally, its anti-inflammatory activity was attributed to the modulation of key signaling pathways, such as NF-κB, which play a critical role in inflammatory responses.

Another area of interest is the compound's potential role in cancer research. Preliminary in vitro studies have shown that 2-Ethyl-6-hydroxybenzoic acid can induce apoptosis in certain cancer cell lines, particularly those associated with breast and colon cancers. Researchers hypothesize that its mechanism of action involves the generation of reactive oxygen species (ROS) and the disruption of mitochondrial function, leading to programmed cell death. These findings, though still in the early stages, open new avenues for exploring its therapeutic applications.

From a pharmaceutical perspective, the compound's pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME), are under investigation to assess its suitability as a drug candidate. Recent pharmacokinetic studies in animal models have provided valuable insights into its bioavailability and metabolic pathways, which are critical for optimizing its formulation and dosing regimens.

In conclusion, 2-Ethyl-6-hydroxybenzoic acid (CAS: 59681-42-4) represents a multifaceted compound with significant potential in chemical, biological, and pharmaceutical research. Its antimicrobial, anti-inflammatory, and anticancer properties, coupled with ongoing studies into its pharmacokinetics, underscore its relevance in modern science. Future research should focus on elucidating its mechanisms of action, improving its synthetic routes, and exploring its clinical applications to fully realize its therapeutic potential.

• 76261-17-1(Benzoic acid, 2-hydroxy-6-(12-phenyldodecyl)-)
• 16611-84-0(Anacardic Acid)
• 58138-55-9(Benzoic acid, 4,5-diethyl-2-hydroxy-)
• 23255-59-6(Lunularic acid)
• 20261-38-5(Ginkgolic Acid (C13:0))
• 4707-50-0(Divarinic Acid)
• 4389-53-1(2-Hydroxy-6-isopropyl-3-methylbenzoic Acid)
• 58138-48-0(Benzoic acid, 5-ethyl-2-hydroxy-4-methyl-)
• 59204-69-2(Benzoic acid, 2-hydroxy-6-tetradecyl-)
• 11034-77-8(Anacardic acid)